Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: | Ferro-F-Malt |
Active Ingredients: | Folic acid 0.55mg Iron polymaltose 370mg equivalent to elemental iron 100mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturer: | XL Laboratories Pvt. Limited, Bhiwadi, India |
Dated this 31st day of October 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).